Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

NCT01265615 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Cardiorenal Syndrome
Chronic Allograft Nephropathy

Interventions

DRUG: Paricalcitol
DRUG: Calcitriol
DRUG: Cholecalciferol
DIETARY_SUPPLEMENT: Supplemental

Sponsor

Ural State Medical University

Collaborators

[object Object]
[object Object]